Skip to main content
logo
Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China flag China · Delayed Price · Currency is CNY
8.26
+0.03 (0.36%)
Jul 31, 2026, 3:04 PM CST

SHE:300009 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Revenue
2,5592,6472,5362,8662,3312,169
Revenue Growth
2.02%4.36%-11.51%22.94%7.48%27.47%
Gross Profit
1,9121,9861,9552,2401,8181,733
Operating Income
746.98800.39759.09912.92755.7599.3
Net Income
693.78735.19706.95847.23703.26206.63
Earnings Per Share
0.420.440.420.510.430.13
EPS Growth
2.08%4.76%-17.03%17.72%230.77%-40.91%

Revenue by Segment
Chart
Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Dec '21
Biological Products
1,9801,8652,1001,5561,295
Chinese Patent Medicine
289.17298.97358.25404.44518.74
Synthetic drugs
150.25151.13178.58147.47134.65
Active Pharmaceutical Ingredient (API)
101.58103.2491.7772.3562.56
Technical Services
24.7331.6258.3476.3994.64
Others
100.8885.6979.0474.2254.53
Total
2,6472,5362,8662,3312,160

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Investments
1,6581,5831,4441,4561,1671,128
Total Debt
30.2432.9653.9656.6333.1427.04
Net Cash (Debt)
1,6271,5501,3901,3991,1341,101
Net Cash Growth
41.84%11.54%-0.66%23.35%3.03%25.04%
Net Cash Per Share
0.980.930.830.840.690.69

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Cash Flow
808.82863.22685.37952.97698.98592.17
Capital Expenditures
-129.79-126.89-117.22-195.34-474.34-131.23
Free Cash Flow
679.03736.33568.15757.64224.64460.94
Free Cash Flow Growth
5.80%29.60%-25.01%237.27%-51.27%41.27%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Gross Margin
74.68%75.04%77.08%78.15%77.97%79.89%
Operating Margin
29.18%30.24%29.93%31.86%32.42%27.63%
Pretax Margin
30.57%31.48%31.66%32.10%35.77%13.61%
Profit Margin
27.11%27.78%27.88%29.56%30.17%9.53%
FCF Margin
26.53%27.82%22.40%26.44%9.64%21.25%

Dividends
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Dividend Per Share
0.2500.2500.2500.2500.2500.200
Dividend Per Share Growth
0%0%0%0%25.00%19.98%
Dividend Yield
3.03%2.69%3.07%2.67%2.99%1.74%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
PE Ratio
19.7021.7220.3920.1822.21103.80
Forward PE
17.5714.1614.1617.4721.2735.62
P/FCF Ratio
20.2821.6825.3722.5669.5546.53
PS Ratio
5.386.035.685.976.709.89